Literature DB >> 31392159

Molecular subtyping, tumor infiltration, and trimodal therapy for muscle-invasive bladder cancer: more questions than answers.

Ronald Kool1, José João Mansure1, Wassim Kassouf2.   

Abstract

Entities:  

Year:  2019        PMID： 31392159      PMCID： PMC6642967          DOI： 10.21037/tau.2019.05.12

Source DB:  PubMed          Journal:  Transl Androl Urol        ISSN： 2223-4683


× No keyword cloud information.
  20 in total

1.  Long-term Outcomes After Bladder-preserving Tri-modality Therapy for Patients with Muscle-invasive Bladder Cancer: An Updated Analysis of the Massachusetts General Hospital Experience.

Authors:  Nicholas J Giacalone; William U Shipley; Rebecca H Clayman; Andrzej Niemierko; Michael Drumm; Niall M Heney; Marc D Michaelson; Richard J Lee; Philip J Saylor; Matthew F Wszolek; Adam S Feldman; Douglas M Dahl; Anthony L Zietman; Jason A Efstathiou
Journal:  Eur Urol       Date:  2017-01-09       Impact factor: 20.096

2.  Anal cancer - a review.

Authors:  Sajad Ahmad Salati; Azzam Al Kadi
Journal:  Int J Health Sci (Qassim)       Date:  2012-06

Review 3.  Critical analysis of bladder sparing with trimodal therapy in muscle-invasive bladder cancer: a systematic review.

Authors:  Guillaume Ploussard; Siamak Daneshmand; Jason A Efstathiou; Harry W Herr; Nicholas D James; Claus M Rödel; Shahrokh F Shariat; William U Shipley; Cora N Sternberg; George N Thalmann; Wassim Kassouf
Journal:  Eur Urol       Date:  2014-02-26       Impact factor: 20.096

4.  Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant Chemotherapy.

Authors:  Roland Seiler; Hussam Al Deen Ashab; Nicholas Erho; Bas W G van Rhijn; Brian Winters; James Douglas; Kim E Van Kessel; Elisabeth E Fransen van de Putte; Matthew Sommerlad; Natalie Q Wang; Voleak Choeurng; Ewan A Gibb; Beatrix Palmer-Aronsten; Lucia L Lam; Christine Buerki; Elai Davicioni; Gottfrid Sjödahl; Jordan Kardos; Katherine A Hoadley; Seth P Lerner; David J McConkey; Woonyoung Choi; William Y Kim; Bernhard Kiss; George N Thalmann; Tilman Todenhöfer; Simon J Crabb; Scott North; Ellen C Zwarthoff; Joost L Boormans; Jonathan Wright; Marc Dall'Era; Michiel S van der Heijden; Peter C Black
Journal:  Eur Urol       Date:  2017-04-05       Impact factor: 20.096

5.  Identification of distinct basal and luminal subtypes of muscle-invasive bladder cancer with different sensitivities to frontline chemotherapy.

Authors:  Woonyoung Choi; Sima Porten; Seungchan Kim; Daniel Willis; Elizabeth R Plimack; Jean Hoffman-Censits; Beat Roth; Tiewei Cheng; Mai Tran; I-Ling Lee; Jonathan Melquist; Jolanta Bondaruk; Tadeusz Majewski; Shizhen Zhang; Shanna Pretzsch; Keith Baggerly; Arlene Siefker-Radtke; Bogdan Czerniak; Colin P N Dinney; David J McConkey
Journal:  Cancer Cell       Date:  2014-02-10       Impact factor: 31.743

Review 6.  ICUD-EAU International Consultation on Bladder Cancer 2012: Radical cystectomy and bladder preservation for muscle-invasive urothelial carcinoma of the bladder.

Authors:  Georgios Gakis; Jason Efstathiou; Seth P Lerner; Michael S Cookson; Kirk A Keegan; Khurshid A Guru; William U Shipley; Axel Heidenreich; Mark P Schoenberg; Arthur I Sagaloswky; Mark S Soloway; Arnulf Stenzl
Journal:  Eur Urol       Date:  2012-08-14       Impact factor: 20.096

Review 7.  The prognostic influence of tumour-infiltrating lymphocytes in cancer: a systematic review with meta-analysis.

Authors:  M J M Gooden; G H de Bock; N Leffers; T Daemen; H W Nijman
Journal:  Br J Cancer       Date:  2011-05-31       Impact factor: 7.640

8.  Prognostic role of tumor-infiltrating lymphocytes in gastric cancer: a meta-analysis.

Authors:  Xiao Zheng; Xing Song; Yingjie Shao; Bin Xu; Lujun Chen; Qi Zhou; Wenwei Hu; Dachuan Zhang; Changping Wu; Min Tao; Yibei Zhu; Jingting Jiang
Journal:  Oncotarget       Date:  2017-05-22

9.  Clinical and patient-reported outcomes of SPARE - a randomised feasibility study of selective bladder preservation versus radical cystectomy.

Authors:  Robert A Huddart; Alison Birtle; Lauren Maynard; Mark Beresford; Jane Blazeby; Jenny Donovan; John D Kelly; Tony Kirkbank; Duncan B McLaren; Graham Mead; Clare Moynihan; Raj Persad; Christopher Scrase; Rebecca Lewis; Emma Hall
Journal:  BJU Int       Date:  2017-05-29       Impact factor: 5.588

10.  The prognostic value of tumor-infiltrating T lymphocytes in ovarian cancer.

Authors:  Jun Li; Jieyu Wang; Ruifang Chen; Yang Bai; Xin Lu
Journal:  Oncotarget       Date:  2017-02-28
View more
  1 in total

1.  Bladder cancer under staging: still unavoidable?

Authors:  Angelo Naselli; Andrea Guarneri
Journal:  Transl Androl Urol       Date:  2019-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.